Darolutamide is an antiandrogen active pharmaceutical ingredient used in the manufacture of medications for prostate cancer. It is typically administered twice daily with food as part of hormonal therapy.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1297538-32-9
Ketodarolutamide
pharmaceutical raw material
Rifalazil
pharmaceutical raw material
Dapoxetine hydrochloride
pharmaceutical raw material
(2R,3ar,6ar)-1-((2S)-2-(((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)propanoyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
pharmaceutical raw material
Selank
pharmaceutical raw material
N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
BLIJXOOIHRSQRB-PXYINDEMSA-N
C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O